Plenary Session: Investing in Global Health Security: Overcoming Challenges in Antibiotic Development
03 December, 2020 3:00PM – 4:00PM CET / 9:00AM – 10:00AM EST
This panel will highlight research and collaborations to develop new tools to tackle AMR and provide an update on efforts to facilitate development and uptake of innovation. While these tools may be years from approval, policy engagement to address identified barriers must begin now.
Moderator: Gregory Frank, PhD, Senior Director, Infectious Disease Policy, BIO
- Pierre Daram, Global Project Leader, Associate Director Portfolio Management, Debiopharm
- Silas Holland, Head of External Affairs (Interim), AMR Action Fund
- Jeremy Knox, Policy and Advocacy Lead, Drug Resistant Infections Programme, Wellcome Trust
- Karolina Puskarczyk, Senior Manager, Innovation Policy, Pfizer